Jane Street

Jane Street Portfolio holdings

AUM $85.6B
1-Year Est. Return 6.03%
 

Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.

This Quarter Est. Return
1 Year Est. Return
+6.03%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$62B
AUM Growth
+$6.32B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
7,077
New
Increased
Reduced
Closed

Top Buys

1 +$1.07B
2 +$1.01B
3 +$644M
4
RECS icon
Columbia Research Enhanced Core ETF
RECS
+$612M
5
DELL icon
Dell
DELL
+$527M

Top Sells

1 +$1.99B
2 +$1.26B
3 +$809M
4
MSFT icon
Microsoft
MSFT
+$724M
5
CRWV
CoreWeave Inc
CRWV
+$711M

Sector Composition

1 Technology 18.93%
2 Financials 9.8%
3 Consumer Discretionary 8.69%
4 Industrials 8.25%
5 Communication Services 6.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LMFA icon
4951
LM Funding America
LMFA
$11.2M
$70.4K ﹤0.01%
+24,609
QTTB icon
4952
Q32 Bio
QTTB
$26.3M
$69.5K ﹤0.01%
+46,635
UFI icon
4953
UNIFI
UFI
$63.3M
$69.3K ﹤0.01%
13,273
+16
RLMD icon
4954
Relmada Therapeutics
RLMD
$290M
$68.6K ﹤0.01%
+114,354
ENLV icon
4955
Enlivex Therapeutics
ENLV
$24.1M
$68.4K ﹤0.01%
61,052
-19,707
AGL icon
4956
Agilon Health
AGL
$239M
$68.1K ﹤0.01%
+29,598
INNV icon
4957
InnovAge Holding
INNV
$657M
$67.6K ﹤0.01%
18,323
-28,504
PRME icon
4958
Prime Medicine
PRME
$608M
$67K ﹤0.01%
+27,145
ARTV
4959
Artiva Biotherapeutics
ARTV
$79.4M
$66.8K ﹤0.01%
+44,215
NINE icon
4960
Nine Energy Service
NINE
$19.5M
$66.4K ﹤0.01%
86,058
+72,915
MTEK icon
4961
Maris-Tech
MTEK
$9.2M
$66K ﹤0.01%
+20,619
DLHC icon
4962
DLH Holdings
DLHC
$86M
$65K ﹤0.01%
+11,125
BGFV
4963
DELISTED
Big 5 Sporting Goods
BGFV
$63.4K ﹤0.01%
+44,641
CANG
4964
Cango
CANG
$544M
$62.5K ﹤0.01%
+12,880
MIST icon
4965
Milestone Pharmaceuticals
MIST
$170M
$62K ﹤0.01%
+31,933
TELO icon
4966
Telomir Pharmaceuticals
TELO
$46.4M
$61.9K ﹤0.01%
+49,556
HIX
4967
Western Asset High Income Fund II
HIX
$380M
$61.5K ﹤0.01%
14,339
-936
AIRS icon
4968
AirSculpt Technologies
AIRS
$342M
$60.4K ﹤0.01%
+12,509
STGW icon
4969
Stagwell
STGW
$1.21B
$60.4K ﹤0.01%
13,411
-109,589
FBLG icon
4970
FibroBiologics
FBLG
$18.9M
$59.8K ﹤0.01%
+96,110
SMXT icon
4971
Solarmax Technology
SMXT
$53.2M
$59.7K ﹤0.01%
+54,796
GUT
4972
Gabelli Utility Trust
GUT
$534M
$59.5K ﹤0.01%
+10,266
CIK
4973
Credit Suisse Asset Management Income Fund
CIK
$155M
$59.4K ﹤0.01%
+20,064
SKYX icon
4974
SKYX Platforms
SKYX
$204M
$59.2K ﹤0.01%
56,612
-133,653
CARM
4975
DELISTED
Carisma Therapeutics
CARM
$59.1K ﹤0.01%
+150,810